Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer.
Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer. Cancer Res. 2005 Nov 15; 65(22):10562-8.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
CD2 Antigens
CD59 Antigens
Cell Line, Tumor
Complement C3
Complement System Proteins
Immunoglobulin M
Lymphoma
Male
Mice
Mice, Inbred C57BL
Receptors, IgG
authors with profiles
Stephen Tomlinson